참고문헌
- The Korean Pediatric Society. Pneumococcal vaccine. In: Lee HJ, editor. Immunization Guideline. 7th ed. Seoul: The Korean Pediatric Society; 2012. pp. 160-74.
- Lagergard T and Branefors P. Nature of cross-reactivity between Haemophilus influenzae types A and B and Streptococcus pneumoniae types 6A and 6B. Acta Pathol Microbiol Immunol Scand 1983;91:371-6.
- Jakobsen H, Sigurdsson VD, Sigurdardottir S, Schulz D, Jonsdottir I. Pneumococcal serotype 19F conjugate vaccine induces cross-protective immunity to serotype 19A in a murine pneumococcal pneumonia model. Infect Immun 2003;71:2956-9. https://doi.org/10.1128/IAI.71.5.2956-2959.2003
- Lee CJ, Lee LH, Frasch CE. Protective immunity of pneumococcal glycoconjugates. Crit Rev Microbiol 2003;29:333-49. https://doi.org/10.1080/713608018
- Saeland E, Jakobsen H, Ingolfsdottir G, Sigurdardottir ST, Jonsdottir I. Serum samples from infants vaccinated with a pneumococcal conjugate vaccine, PncT, protect mice against invasive infection caused by Streptococcus pneumoniae serotypes 6A and 6B. J Infect Dis 2001;183:253-60. https://doi.org/10.1086/317934
- Richter SS, Heilmann KP, Dohrn CL, Riahi F, Beekmann SE, Doern GV. Changing epidemiology of antimicrobialresistant Streptococcus pneumoniae in the United States, 2004-2005. Clin Infect Dis 2009;48:e23-33. https://doi.org/10.1086/595857
- Cohen R. The need for prudent use of antibiotics and routine use of vaccines. Clin Microbiol Infect 2009;15(Suppl 3):S21-3.
- Choi EH, Kim KH, Kim YJ, Kim JH, Park SE, Lee HJ, et al. Recommendation for use of the newly introduced pneumococcal protein conjugate vaccines in Korea. Korean J Pediatr 2011;54:146-51. https://doi.org/10.3345/kjp.2011.54.4.146
- Kim KH, Hong JY, Lee H, Kwak GY, Nam CH, Lee YS, et al. Nasopharyngeal pneumococcal carriage of children attending day care centers in Korea: comparison between children immunized with 7-valent pneumococcal conjugate vaccine and non-immunized. J Korean Med Sci 2011;26:184-90. https://doi.org/10.3346/jkms.2011.26.2.184
- Pelton SI, Huot H, Finkelstein JA, Bishop CJ, Hsu KK, Kellenber J, et al. Emergence of 19A as virulent and multidrug resistant Pneumococcus in Massachusetts following universal immunization of infants with pneumococcal coccal conjugate vaccine. Pediatr Infect Dis J 2007;26:468-72. https://doi.org/10.1097/INF.0b013e31803df9ca
- Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 2007;45:1225-33. https://doi.org/10.1128/JCM.02199-06
- Park IH, Moore MR, Treanor JJ, Pelton SI, Pilishvili T, Beall B, et al. Differential effects of pneumococcal vaccines against serotypes 6A and 6C. J Infect Dis 2008;198:1818-22. https://doi.org/10.1086/593339
- Lee H, Nahm MH, Burton R, Kim KH. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A. Clin Vaccine Immunol 2009;16:376-81. https://doi.org/10.1128/CVI.00344-08
- Bryant KA, Block SL, Baker SA, Gruber WC, Scott DA. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine. Pediatrics 2010;125:866-75. https://doi.org/10.1542/peds.2009-1405
- Nuorti JP and Whitney CG. Prevention of pneumococcal disease among infants and children - use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine - recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010;59:1-18.
- Lee HJ, Park SE, Kim KH. Immune response to 19A serotype after immunization of 19F containing pneumococcal conjugate vaccine in Korean children aged 12-23 months. Korean J Pediatr 2011;54:163-8. https://doi.org/10.3345/kjp.2011.54.4.163
- Cha JH. Immune responses against serogroup 6 (6A, 6B, 6C, and 6D) among subjects vaccinated with the 7-valent pneumococcal conjugate vaccine. Ph.D. dissertation, School of Medicine, Ewha Womans University, Seoul 2012
- Simell B, Nurkka A, Ekstrom N, Givon-Lavi N, Kayhty H, Dagan R. Serum IgM antibodies contribute to high levels of opsonophagocytic activities in toddlers immunized with a single dose of the 9-valent pneumococcal conjugate vaccine. Clin Vaccine Immunol 2012;19:1618-23. https://doi.org/10.1128/CVI.00248-12
- Burton RL and Nahm MH. Development and validation of a fourfold multiplexed opsonization assay (MOPA4) for pneumococcal antibodies. Clin Vaccine Immunol 2006;13:1004-9. https://doi.org/10.1128/CVI.00112-06
- Mond JJ, Lees A, Snapper CM. T cell-independent antigens type 2. Annu Rev Immunol 1995;13:655-92. https://doi.org/10.1146/annurev.iy.13.040195.003255
- de Vinuesa CG, Cook MC, Ball J, Sunners Y, Cascalho M, Wabl M, et al. Germinal centers without T cells. J Exp Med 2000;191:485-94. https://doi.org/10.1084/jem.191.3.485
- Lentz VM and Manser T. Cutting edge: germinal centers can be induced in the absence of T cells. J Immunol 2001;167:15-20. https://doi.org/10.4049/jimmunol.167.1.15
- Toellner KM, Jenkinson WE, Taylor DR, Khan M, Sze DMY, Sansom DM, et al. Low-level hypermutation in T cell-independent germinal centers compared with high mutation rates associated with T cell-dependent germinal centers. J Exp Med 2002;195:383-9. https://doi.org/10.1084/jem.20011112
- Obukhanych TV and Nussenzweig MC. T-independent type II immune responses generate memory B cells. J Exp Med 2006;203:305-10. https://doi.org/10.1084/jem.20052036
- Shi Y, Yamazaki T, Okubo Y, Uehara Y, Sugane K, Agematsu K. Regulation of aged humoral immune defense against pneumococcal bacteria by IgM memory B cell. J Immunol 2005;175:3262-7. https://doi.org/10.4049/jimmunol.175.5.3262
-
Maxwell KF, Powell MS, Hulett MD, Barton PA, Mc- Kenzie IFC, Garrett TPJ, et al. Crystal structure of the human leukocyte Fc receptor, Fc
$\gamma$ RIIa. Nat Struct Biol 1999;6:437-42. https://doi.org/10.1038/8241 -
Yee AM, Phan HM, Zuniga R, Salmon JE, Musher DM. Association between Fc
$\gamma$ RIIa-R131 allotype and bacteremic pneumococcal pneumonia. Clin Infect Dis 2000;30:25-8. https://doi.org/10.1086/313588 -
Yuan FF, Wong M, Pererva N, Keating J, Davis AR, Bryant JA, et al. Fc
$\gamma$ RIIA polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 2003;81:192-5. https://doi.org/10.1046/j.1440-1711.2003.01158.x - Stray-Pedersen A, Aaberge IS, Fruh A, Abrahamsen TG. Pneumococcal conjugate vaccine followed by pneumococcal polysaccharide vaccine; immunogenicity in patients with ataxia-telangiectasia. Clin Exp Immunol 2005;140:507-16. https://doi.org/10.1111/j.1365-2249.2005.02791.x
- Mackenzie GA, Carapetis JR, Leach AJ, Morris PS. Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination. BMC pediatr 2009;9:14. https://doi.org/10.1186/1471-2431-9-14
- Baxendale HE, Johnson M, Stephens RC, Yuste J, Klein N, Brown JS, et al. Natural human antibodies to pneumococcus have distinctive molecular characteristics and protect against pneumococcal disease. Clin Exp Immunol 2008;151:51-60.
- Raff HV, Bradley C, Brady W, Donaldson K, Lipsich L, Maloney G, et al. Comparison of functional activities between IgG1 and IgM class-switched human monoclonal antibodies reactive with group B streptococci or Escherichia coli K1. J Infect Dis 1991;163:346-54. https://doi.org/10.1093/infdis/163.2.346
- Shyur SD, Raff HV, Bohnsack JF, Kelsey DK, Hill HR. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci. J Immunol 1992;148:1879-84.